GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) » Definitions » Accounts Receivable

Dizal (Jiangsu) Pharmaceutical Co (SHSE:688192) Accounts Receivable : ¥45.4 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Dizal (Jiangsu) Pharmaceutical Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Dizal (Jiangsu) Pharmaceutical Co's accounts receivables for the quarter that ended in Mar. 2025 was ¥45.4 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Dizal (Jiangsu) Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 was 25.97.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Dizal (Jiangsu) Pharmaceutical Co's Net-Net Working Capital per share for the quarter that ended in Mar. 2025 was ¥-1.82.


Dizal (Jiangsu) Pharmaceutical Co Accounts Receivable Historical Data

The historical data trend for Dizal (Jiangsu) Pharmaceutical Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dizal (Jiangsu) Pharmaceutical Co Accounts Receivable Chart

Dizal (Jiangsu) Pharmaceutical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Receivable
Get a 7-Day Free Trial 6.90 7.55 - 48.04 27.50

Dizal (Jiangsu) Pharmaceutical Co Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.13 93.70 80.92 27.50 45.43

Dizal (Jiangsu) Pharmaceutical Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Dizal (Jiangsu) Pharmaceutical Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Dizal (Jiangsu) Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=45.434/159.641*91
=25.97

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Dizal (Jiangsu) Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Dizal (Jiangsu) Pharmaceutical Co's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2025 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(898.762+0.75 * 45.434+0.5 * 37.543-1781.305
-0-5.074)/459.413
=-1.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Dizal (Jiangsu) Pharmaceutical Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Dizal (Jiangsu) Pharmaceutical Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Dizal (Jiangsu) Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Jinghui East Road, Room 4105, Building E (Building 5), Huirong Business Plaza, Xinwu District, Jiangsu Province, Wuxi City, CHN, 201203
Dizal (Jiangsu) Pharmaceutical Co Ltd is engaged in the research and development, production and sales of innovative drugs.
Executives
Directors, senior managers, core technical personn
Qiao Wei Jun Core technical personnel
Wu Qing Yi senior management
Lv Hong Bin senior management
Directors, senior managers
Senior management, core technical personnel
Zheng Li Core technical personnel
Yang Zhen Fan Senior management, core technical personnel
Senior management, core technical personnel
Chen Kan Core technical personnel
Chen Su Qin Senior management, core technical personnel
Zhang Zhi Wei senior management
Senior management, core technical personnel
Senior management, core technical personnel

Dizal (Jiangsu) Pharmaceutical Co Headlines

No Headlines